Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

DJ US Pharmaceuticals Ishares (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [AMEX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fund basics

See More
  • Fund Family BlackRock
  • Assets Under Management 710,820,100
  • Shares Outstanding, K 4,500

Price Performance

See More
Period Period Low Period High Performance
1-Month
153.92 +2.87%
on 07/07/17
160.92 -1.61%
on 06/22/17
+1.13 (+0.72%)
since 06/21/17
3-Month
147.49 +7.35%
on 05/18/17
160.92 -1.61%
on 06/22/17
+10.01 (+6.75%)
since 04/21/17
52-Week
129.20 +22.55%
on 11/04/16
160.92 -1.61%
on 06/22/17
+5.19 (+3.39%)
since 07/21/16

Most Recent Stories

More News
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 80.99 (-0.11%)
VHT : 150.56 (-0.05%)
JNJ : 135.31 (-0.92%)
IHE : 158.33 (-0.01%)
IYH : 169.80 (-0.11%)
FHLC : 39.08 (+0.03%)
J&J Brightens Outlook: Healthcare ETFs in Focus

Johnson & Johnson continued its long streak of earnings beat and offered an upbeat outlook for the full year. However, it lagged our revenue estimate.

XLV : 80.99 (-0.11%)
VHT : 150.56 (-0.05%)
JNJ : 135.31 (-0.92%)
IHE : 158.33 (-0.01%)
IYH : 169.80 (-0.11%)
FHLC : 39.08 (+0.03%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 44.32 (+0.18%)
PJP : 64.71 (+0.23%)
IHE : 158.33 (-0.01%)
PPH : 59.15 (+0.10%)
What Lies Ahead for Pharma ETFs in Second Half 2017

We discuss some of the factors that could contribute to a sustained recovery in the sector.

XPH : 44.32 (+0.18%)
PJP : 64.71 (+0.23%)
IHE : 158.33 (-0.01%)
PPH : 59.15 (+0.10%)
The Latest Market Trends Every Biopharma Investor Needs to Know

Speaking at MedCity INVEST, a national healthcare investing conference in Chicago hosted by MedCity News, Jonathan Norris of Silicon Valley Bank, alongside Ryan Jalowiecki from PwC, highlighted the latest...

IHE : 158.33 (-0.01%)
IBB : 324.88 (+0.61%)
XBI : 80.77 (+0.79%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 80.99 (-0.11%)
VHT : 150.56 (-0.05%)
JNJ : 135.31 (-0.92%)
IHE : 158.33 (-0.01%)
IYH : 169.80 (-0.11%)
FHLC : 39.08 (+0.03%)
PFE : 33.48 (-0.18%)
Lackluster J&J Q1 Pushes Healthcare ETFs Down

Johnson & Johnson continued its long streak of earnings beat but lagged our revenue estimate again on sluggish drug sales.

XLV : 80.99 (-0.11%)
VHT : 150.56 (-0.05%)
JNJ : 135.31 (-0.92%)
IHE : 158.33 (-0.01%)
IYH : 169.80 (-0.11%)
FHLC : 39.08 (+0.03%)
PFE : 33.48 (-0.18%)
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs

With the failure of Trumpcare, the healthcare sector looks more stable.

UHS : 124.42 (-0.46%)
BBC : 25.25 (+0.44%)
AC : 33.80 (+0.90%)
XLV : 80.99 (-0.11%)
IHE : 158.33 (-0.01%)
MOH : 71.15 (-1.25%)
LPNT : 65.35 (-0.23%)
THC : 20.65 (-0.10%)
BBP : 41.00 (+0.59%)
XPH : 44.32 (+0.18%)
PBE : 47.45 (+0.13%)
SBIO : 29.17 (+0.24%)
PJP : 64.71 (+0.23%)
CNC : 84.73 (-0.78%)
SPY : 246.88 (-0.09%)
XBI : 80.77 (+0.79%)
Trumpcare Collapse Fuels Rally in Healthcare Stocks & ETFs

With the failure of Trumpcare, the healthcare sector looks more stable.

UHS : 124.42 (-0.46%)
BBC : 25.25 (+0.44%)
AC : 33.80 (+0.90%)
XLV : 80.99 (-0.11%)
IHE : 158.33 (-0.01%)
MOH : 71.15 (-1.25%)
LPNT : 65.35 (-0.23%)
THC : 20.65 (-0.10%)
BBP : 41.00 (+0.59%)
XPH : 44.32 (+0.18%)
PBE : 47.45 (+0.13%)
SBIO : 29.17 (+0.24%)
PJP : 64.71 (+0.23%)
CNC : 84.73 (-0.78%)
SPY : 246.88 (-0.09%)
XBI : 80.77 (+0.79%)
Should You Buy Pharma ETFs Now?

After a challenging 2016, are Pharma ETFs poised to rebound this year?

XPH : 44.32 (+0.18%)
PJP : 64.71 (+0.23%)
IHE : 158.33 (-0.01%)
PPH : 59.15 (+0.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Support & Resistance

2nd Resistance Point 159.22
1st Resistance Point 158.77
Last Price 158.33
1st Support Level 157.75
2nd Support Level 157.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.